NVCR Insider Transactions
951 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–100; provenance stays internal.
NVCR insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Leonard Frank X | Chief Executive Officer | 2026-06-04 | Sale | 34,273.0 | $17.93 |
| Stafford Kristin | Director | 2026-06-02 | Sale | 2,945.0 | $15.77 |
| Ocean Allyson J | Director | 2026-06-02 | Sale | 2,945.0 | $15.77 |
| Scannell Timothy J | Director | 2026-06-02 | Sale | 2,945.0 | $15.77 |
| VERNON W ANTHONY | Director | 2026-06-02 | Sale | 2,945.0 | $15.77 |
| Hung David | Director | 2026-06-02 | Sale | 2,945.0 | $15.77 |
| LEUNG GABRIEL | Director | 2026-06-02 | Sale | 2,945.0 | $15.77 |
| HILLEMAN JERYL L | Director | 2026-06-02 | Sale | 2,945.0 | $15.77 |
| Paravasthu Mukund | Chief Operating Officer | 2026-03-05 | Sale | 43,246.0 | $13.77 |
| Brackmann Christoph | Chief Financial Officer | 2026-03-04 | Sale | 6,412.0 | $13.31 |
| Paravasthu Mukund | Chief Operating Officer | 2026-03-04 | Sale | 5,377.0 | $13.31 |
| Leupin Nicolas | Former Chief Medical Officer | 2026-03-04 | Sale | 1,100.0 | $13.31 |
| Puri Michal Nath | Chief Human Resources Officer | 2026-03-04 | Sale | 1,100.0 | $13.31 |
| Leonard Frank X | Chief Executive Officer | 2026-03-04 | Sale | 5,607.0 | $13.31 |
| Weinberg Uri | Chf Medical and Innovation Ofr | 2026-03-04 | Sale | 6,412.0 | $13.31 |
| DOYLE WILLIAM F | Executive Chairman | 2026-03-03 | Sale | 21,330.0 | $13.43 |
| DOYLE WILLIAM F | Executive Chairman | 2026-03-03 | Sale | 50,557.0 | $12.79 |
| Paravasthu Mukund | Chief Operating Officer | 2026-03-02 | Sale | 408.0 | $13.49 |
| Leonard Frank X | Chief Executive Officer | 2026-03-02 | Sale | 7,232.0 | $13.49 |
| Weinberg Uri | Chf Medical and Innovation Ofr | 2026-03-02 | Sale | 3,272.0 | $13.33 |
| Paravasthu Mukund | Chief Operating Officer | 2026-02-27 | Sale | 1,555.0 | $13.66 |
| Leupin Nicolas | Former Chief Medical Officer | 2026-02-27 | Sale | 1,029.0 | $13.66 |
| Puri Michal Nath | Chief Human Resources Officer | 2026-02-27 | Sale | 1,441.0 | $13.66 |
| Leonard Frank X | Chief Executive Officer | 2026-02-27 | Sale | 9,734.0 | $13.66 |
| Weinberg Uri | Chf Medical and Innovation Ofr | 2026-02-27 | Sale | 7,461.0 | $13.84 |
| Cordova Ashley | Chief Executive Officer | 2025-09-05 | Purchase | 81,550.0 | $12.22 |
| Brackmann Christoph | Chief Financial Officer | 2025-07-29 | Purchase | 5,000.0 | $11.5 |
| Brackmann Christoph | Chief Financial Officer | 2025-07-29 | Purchase | 5,000.0 | $11.6 |
| Brackmann Christoph | Chief Financial Officer | 2025-07-29 | Purchase | 10,000.0 | $11.63 |
| Stafford Kristin | Director | 2025-06-03 | Sale | 999.0 | $17.28 |
| LEUNG GABRIEL | Director | 2025-06-03 | Sale | 999.0 | $17.31 |
| Madden Martin J. | Director | 2025-06-03 | Sale | 999.0 | $17.19 |
| Scannell Timothy J | Director | 2025-06-03 | Sale | 999.0 | $17.32 |
| HILLEMAN JERYL L | Director | 2025-06-03 | Sale | 999.0 | $17.26 |
| Ocean Allyson J | Director | 2025-06-03 | Sale | 999.0 | $17.29 |
| VERNON W ANTHONY | Director | 2025-06-03 | Sale | 999.0 | $17.35 |
| Hung David | Director | 2025-06-03 | Sale | 999.0 | $17.3 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | 2025-06-02 | Sale | 1,879.0 | $19.01 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | 2025-06-02 | Sale | 6,600.0 | $17.99 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | 2025-06-02 | Sale | 21,717.0 | $17.22 |
| Paravasthu Mukund | Chief Operating Officer | 2025-05-03 | Sale | 592.0 | $17.91 |
| Weinberg Uri | Chief Innovation Officer | 2025-03-03 | Sale | 268.0 | $18.92 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | 2025-03-03 | Sale | 2,527.0 | $18.54 |
| Cordova Ashley | Chief Executive Officer | 2025-03-03 | Sale | 2,053.0 | $18.54 |
| Paravasthu Mukund | Chief Operating Officer | 2025-03-03 | Sale | 250.0 | $18.54 |
| Weinberg Uri | Chief Innovation Officer | 2025-02-28 | Sale | 311.0 | $18.31 |
| Weinberg Uri | Chief Innovation Officer | 2025-02-28 | Sale | 4,326.0 | $18.78 |
| Cordova Ashley | Chief Executive Officer | 2025-02-28 | Sale | 2,341.0 | $18.28 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | 2025-02-28 | Sale | 2,770.0 | $18.28 |
| Paravasthu Mukund | Chief Operating Officer | 2025-02-28 | Sale | 368.0 | $18.28 |
| Weinberg Uri | Chief Innovation Officer | 2025-02-28 | Sale | 311.0 | $18.31 |
| Weinberg Uri | Chief Innovation Officer | 2025-02-28 | Sale | 4,326.0 | $18.78 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | 2025-02-28 | Sale | 2,770.0 | $18.28 |
| Cordova Ashley | Chief Executive Officer | 2025-02-28 | Sale | 2,341.0 | $18.28 |
| Paravasthu Mukund | Chief Operating Officer | 2025-02-28 | Sale | 368.0 | $18.28 |
| Cordova Ashley | Chief Executive Officer | 2025-02-27 | Sale | 1,808.0 | $20.55 |
| Cordova Ashley | Chief Executive Officer | 2025-02-27 | Sale | 9,345.0 | $19.92 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | 2025-02-27 | Sale | 1,989.0 | $20.55 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | 2025-02-27 | Sale | 10,277.0 | $19.92 |
| Puri Michal Nath | Chief Human Resources Officer | 2025-02-27 | Sale | 225.0 | $20.55 |
| Puri Michal Nath | Chief Human Resources Officer | 2025-02-27 | Sale | 1,162.0 | $19.92 |
| Leupin Nicolas | Chief Medical Officer | 2025-02-27 | Sale | 161.0 | $20.55 |
| Leupin Nicolas | Chief Medical Officer | 2025-02-27 | Sale | 830.0 | $19.92 |
| Paravasthu Mukund | Chief Operating Officer | 2025-02-27 | Sale | 267.0 | $20.55 |
| Paravasthu Mukund | Chief Operating Officer | 2025-02-27 | Sale | 1,379.0 | $19.92 |
| Leupin Nicolas | Chief Medical Officer | 2025-02-27 | Sale | 161.0 | $20.55 |
| Leupin Nicolas | Chief Medical Officer | 2025-02-27 | Sale | 830.0 | $19.92 |
| Puri Michal Nath | Chief Human Resources Officer | 2025-02-27 | Sale | 225.0 | $20.55 |
| Puri Michal Nath | Chief Human Resources Officer | 2025-02-27 | Sale | 1,162.0 | $19.92 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | 2025-02-27 | Sale | 1,989.0 | $20.55 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | 2025-02-27 | Sale | 10,277.0 | $19.92 |
| Cordova Ashley | Chief Executive Officer | 2025-02-27 | Sale | 1,808.0 | $20.55 |
| Cordova Ashley | Chief Executive Officer | 2025-02-27 | Sale | 9,345.0 | $19.92 |
| Paravasthu Mukund | Chief Operating Officer | 2025-02-27 | Sale | 267.0 | $20.55 |
| Paravasthu Mukund | Chief Operating Officer | 2025-02-27 | Sale | 1,379.0 | $19.92 |
| Paravasthu Mukund | Chief Operating Officer | 2025-01-11 | Sale | 2,160.0 | $26.81 |
| Paravasthu Mukund | Chief Operating Officer | 2024-11-02 | Sale | 44.0 | $16.69 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | 2024-11-01 | Sale | 598.0 | $15.94 |
| Paravasthu Mukund | Chief Operating Officer | 2024-11-01 | Sale | 160.0 | $15.88 |
| Puri Michal Nath | Chief Human Resources Officer | 2024-10-31 | Sale | 810.0 | $15.79 |
| Cordova Ashley | Chief Financial Officer | 2024-08-02 | Sale | 688.0 | $20.14 |
| VERNON W ANTHONY | Director | 2024-06-04 | Sale | 964.0 | $23.89 |
| Scannell Timothy J | Director | 2024-06-04 | Sale | 964.0 | $23.89 |
| LEUNG GABRIEL | Director | 2024-06-04 | Sale | 964.0 | $23.89 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2024-03-04 | Sale | 1,217.0 | $16.01 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | 2024-03-04 | Sale | 840.0 | $16.01 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2024-03-01 | Sale | 2,107.0 | $16.03 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | 2024-03-01 | Sale | 1,679.0 | $16.03 |
| Leonard Frank X | EVP, Pres., Novocure Oncology | 2024-02-28 | Sale | 2,078.0 | $16.14 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2024-02-28 | Sale | 2,303.0 | $16.14 |
| Shah Pritesh | Chief Growth Officer | 2023-11-07 | Sale | 382.0 | $12.65 |
| Cordova Ashley | Chief Financial Officer | 2023-09-01 | Sale | 883.0 | $21.82 |
| GROENHUYSEN WILHELMUS CM | Chief Operating Officer | 2023-09-01 | Sale | 294.0 | $21.82 |
| Shah Pritesh | Chief Growth Officer | 2023-09-01 | Sale | 273.0 | $21.82 |
| Cordova Ashley | Chief Financial Officer | 2023-08-02 | Sale | 1,144.0 | $30.25 |
| Leonard Frank X | President, CNS Cancers US | 2023-03-07 | Sale | 2,315.0 | $75.59 |
| Leonard Frank X | President, CNS Cancers US | 2023-03-07 | Sale | 6,003.0 | $75.0 |
| Leonard Frank X | President, CNS Cancers US | 2023-03-03 | Sale | 888.0 | $76.16 |
| Leonard Frank X | President, CNS Cancers US | 2023-03-03 | Sale | 4,403.0 | $76.16 |
| Shah Pritesh | Chief Growth Officer | 2023-03-03 | Sale | 16,909.0 | $76.16 |